MedPAC Explores Drug Coverage Plan Problems As Part D Stand-Alone Plan Access Declines

Commission members say the standalone prescription drug plan market needs to be bolstered, given that more than 40% of Medicare beneficiaries in fee-for-service Medicare are enrolled in PDPs.

Drug access could be threatened by a diminished PDP market. (Shutterstock)
Key Takeaways
  • MedPAC is exploring the stability of the Medicare Part D standalone drug plan market given a notable decline in the number and attractiveness of plans available in 2025.

The US Medicare Payment Advisory Commission is analyzing the differences between Medicare outpatient drug coverage in Medicare Advantage plans and stand-alone prescription drug plans, ideally to help preserve stand-alone plans as an ongoing option for beneficiaries.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Geography